Cardio-pulmonary resuscitation device goes into US government-funded trials
This article was originally published in Clinica
A small, relatively simple, breathing device developed by a Minnesota start-up company is one of the clinical trials announced last month as part of a new government-funded collaboration aimed at studying ways to improve survival from cardiac arrest and severe trauma.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.